Brief: Dyadic International And Proliant Health And Biologicals Announce Recombinant Albumin Development And Commercialization Partnership
28/06/2024 13:45
June 28 (Reuters) - Dyadic International Inc DYAI.O :
* DYADIC INTERNATIONAL, INC. AND PROLIANT HEALTH AND
BIOLOGICALS
ANNOUNCE RECOMBINANT ALBUMIN DEVELOPMENT AND COMMERCIALIZATION
PARTNERSHIP
Source text for Eikon: ID:nGNXb82fw1
Further company coverage: DYAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dyadic International
See all newsDyadic International Inc reports results for the quarter ended June 30 - Earnings Summary
Dyadic International Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Dyadic International - Develops C1 Cell Lines And Manufactures Bundibugyo Ebolavirus Antigens Within 15 Days
Brief: Dyadic Announces Continued Listing On The Nasdaq Capital Market
Brief: Dyadic And Scripps Research Collaborate On Rapid-Response Hantavirus Antibody And Vaccine Development